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1. INTRODUCTION 
Voluntary blood donors constitute the safest source of blood ‘contribution’ to 
save the lives of thousands of people every day. In India, any healthy individual 
between the ages of 18 to 65 years can donate blood once in three months interval, 
maximum up to 188 times in their life time.1 Blood Transfusion Service is a vital part of 
the National Health Service and there is no substitute for human blood and its 
components.  
According to WHO, blood donation should be absolutely voluntary and free and 
the motive should be purely altruistic to help the unknown recipient. Blood Safety, 
therefore, remains an issue of major concern in transfusion medicine in developing 
countries where national blood transfusion services and policies, appropriate 
infrastructure, trained personnel and financial resources are lacking.2 The worldwide 
data for the global database for blood safety of the 162 countries 39 countries are not 
routinely testing blood donations for one or more of the four major TTIs.3 
The National Blood Policy in India relies heavily on voluntary blood donors, as 
they are usually assumed to be associated with low levels of transfusion-transmitted 
infections (TTIs). In India, it is mandatory to test every unit of blood collected for 
hepatitis B, hepatitis C, HIV, syphilis and malaria.4  If donors test positive to any of the 
five infections, their blood is discarded. Voluntary blood donors consider themselves to 
be healthy, have no infections to their knowledge and come to the blood bank with the 
intention of helping someone. In order to improve the standards of Blood and its 
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components, the Central Govt. through Drugs Controller General of India, has 
formulated a comprehensive legislation to ensure better quality control system on 
collection, storage, testing and distribution of blood and its components.  Central Govt. 
amended from time to time the existing requirements of Blood Banks in the Drugs & 
Cosmetics Act, 1940 and Rules there under to meet the latest standards.5 
The testing for malaria parasite is mandatory as per the drugs and cosmetic act 
part XII B of schedule F. As per NACO, Ministry of Health and Family Welfare, 
Government of India guidelines 2007, test for malaria in all blood units should be tested 
for malarial parasites using a validated and sensitive antigen tests.4 
 According to the WHO manual 2010 for Screening Donated Blood for 
Transfusion-Transmissible Infections, in malarial endemic areas it is recommended to 
screen all blood units for malarial parasites by thick film or Serological markers to 
detect malarial Antibody/Antigen. The preferable method for samples with low-
parasitemic load is antibody/antigen screening. This is in addition to the donor selection 
and deferral country-specific criteria. 
Transmission of malaria by blood transfusion was one of the first recorded 
incidents of transfusion transmitted infection.6 The frequency of transfusion transmitted 
malaria varies from 0.2 per million cases for non-endemic countries to 50 or more cases 
per million in endemic areas.7 
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 The microscopic detection of blood though considered the gold standard for 
malaria diagnosis for decades, it is quite labor intensive and require adequate technical 
skill and man power. This had spurred the development   of other microscopic malarial 
and rapid detection test based on the detection of malarial parasite antigen in the whole 
blood.8 
There are many studies available regarding transfusion transmitted malaria and 
this study was undertaken to compare the gold standard microscopy with QBC and  
rapid diagnostic test. 
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2. AIM AND OBJECTIVES 
To study the prevalence of malaria among voluntary blood donors.  
To compare the various screening methods and to find out the most sensitive technique 
to screen malarial parasite among voluntary blood donors. 
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3. REVIEW OF LITERATURE 
Blood Transfusion History 
Blood transfusion has evolved over a long period from the time of Hippocrates, 
Where venesection was widely practiced and about one hundred years ago it became the 
part of routine clinical practice.9 The description of systemic blood circulation and 
functions of heart and vessels by William Harvey in 1628 became a major breakthrough 
and a cornerstone of practice for transfusion.10 The first animal to animal transfusion 
was performed by Richard Lower in the year 1666 in Oxford.9  In 1818, James Blundell, 
an obstetrician at Guys and St. Thomas Hospitals in London was credited for the first 
human to human transfusion.11  
 In 1900, Karl Landsteiner categorized human blood groups in to A, B and C. 
Blood group ‘C’ was subsequently renamed as ‘O’ by Landsteiner himself. Later in the 
year 1902 Alfred Decastello and Adriano Sturli, students of Landsteiner found out the 
fourth blood group ‘AB’. 
For Blood transfusion, Ludvig Hektoen advocated selecting donors by blood 
grouping and crossmatching.  Later, in 1913 the importance of crossmatching was 
demonstrated by Reuben Otlenberg on 128 cases of blood transfusion. 
Transfusion reactions were well documented and understood by 1950s when the 
blood transfusion practice expanded. Major and minor reactions occurred, even after the 
introduction of routine typing and crossmatching. 
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 It had been known for some time that blood transfusion transmits syphilis, 
malaria and smallpox.  In 194212 , VDRL test was the first screening test to be made 
mandatory in U.S, since there was a strong suspicion of transmission of syphilis by 
blood transfusion. 
It was during 1953, Paul Beeson, described transfusion transmitted hepatitis. 
Subsequently they found Hepatitis A, B, and C to be transmitted through blood 
transfusion. However, it was the outbreak of AIDS that galvanized the public attention 
to blood transfusion. 
In the year 1985, HIV screening was made mandatory in U.S blood banks. 
Improved donor screening and increased testing have greatly decreased the risk of 
disease transmission and rendered the blood supply safer.  
Blood Transfusion Safety 
  In 1975, 28th World Health Assembly in Geneva passed a resolution to address 
the issue of blood safety. The resolution WHA 28.72 urges member states for the 
development of national blood services on voluntary non remunerated donation of 
blood.13 The aim of Blood Transfusion safety is to ensure that everyone has access to 
blood and blood products which are as safe as possible, adequate to meet the need of 
patients, available at reasonable cost, transfused only when necessary and provides us a 
sustainable blood program within in the health care system.14 
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Current status of Global Health safety 
The World Health Organization global database on blood safety was set up in 
1998 to collect and analyze data from all countries regarding blood and blood product 
safety on the basis of effective action to improve the blood transfusion services 
globally.3 
  Based on the reports from 173 countries15, around ninety three million blood 
donations are donated annually, among them 50% of them are collected in the 
developed countries. The average donation rate in developed countries is 45.4 per 1000 
population in comparison to the transitional and developing countries where 10.1 and 
3.6 per 1000 population respectively. 
The disease transmission depends on the type of donor, their behavior and risk status.  
The following are the various types of donors: 
1. VOLUNTARY DONORS 
  A person who gives blood, plasma or other blood components of his /her own 
free will and receives no payment for it, either in the form of cash or in kind which 
could be considered a substitute for money, this includes time off work other than 
reasonably needed for the donation and travel. Small tokens, refreshments and 
reimbursement of the direct travel costs are compatible with voluntary non-remunerated 
blood donation. He is an altruistic donor, who gives blood fully and willingly.2 
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CATEGORIES OF VOLUNTARY BLOOD DONOR:  
a) New voluntary donor: 
A Voluntary non-remunerated blood donor who has never donated blood before 
b) Lapsed voluntary donor: first write regular donor and then lapsed 
A Voluntary non- remunerated blood donor who has given blood in the past but 
does not fulfill the criteria for a regular donor 
c) Regular voluntary donor : 
A Voluntary non-remunerated blood donor who has donated at least three times, 
the last donation being within the previous year and continuous to donate 
regularly at least once per year. 
2. OTHER CATEGORIES OF BLOOD DONORS 
1) FAMILY / REPLACEMENT BLOOD DONOR2: 
a) A donor who gives blood when it is required by a member of the 
patients’ family or community. This may involve a hidden paid donation 
system in which the donor is paid by the patients’ family. 
b) A family / replacement donor is one who gives blood when it is required 
by a member of his/her family or community. This often involves 
concern and or payment which compromise the safety of the blood. 
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c) A member of the family or a friend of the patient who donates blood in 
replacement of blood needed for the particular patient without 
involvement of any monetary or other benefits from any source. 
2) PAID / PROFESSIONAL DONOR: 
A donor who donates blood in exchange of money or other forms of payment is 
called a professional donor. It is banned in India from 1st Jan 1998.2 
Voluntary blood donors are the cornerstone of a safe and adequate supply of 
blood and blood products. The safest blood donors are voluntary, non-remunerated. 
Despite this notion, family / replacement donors still provide more than 45% of blood 
collected in India.2 
Many reports confirm that paid donors and replacement donors have a higher 
prevalence of TTI. In a study conducted by Gupta et al (New Delhi) in 2006 among 
armed forces, seropositivity of HIV, anti-HCV, HbsAg show an increase in reactivity 
rate in replacement donor compared to voluntary donors.16 
For a safe blood service in our country, where comprehensive test are neither 
possible nor pragmatic, it is best to switch over to 100% voluntary blood donation 
which provides the safest blood. 
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 Transfusion Transmitted Infections 
Viral Infection  
The transmission of viral agent through blood transfusion was reported in 
1943.17, 18 Important transfusion transmitted viruses are Human Immunodeficiency 
Viruses Type 1 and Type 2, Hepatitis B, Hepatitis C, Human T-Cell Lymphotrophic 
Virus Type I and Type II. Other viruses include Epstein – Barr virus, Parvovirus B19, 
Westnile virus, GB virus C can also be transmitted through blood products19. The risk 
of transfusion transmitted viral infection has been reduced to minimal level in 
developed countries, but in developing countries the risk is very higher.20 
Parasitic infection 
The transmission of parasitic infection (malarial parasite) through blood 
transfusion was reported in 1911.Later, Babesia microti and Trypanosoma cruzi were 
found to be transmitted through blood transfusion. Babesiosis and Chagas disease show 
an increased threat to donors in developed countries. However, transfusion transmitted 
malaria is a major problem in developing countries.21 
Emerging Infections 
The American Association of Blood Bank has recently identified 68 infectious 
diseases that can be transmitted by transfusion.22  In spite of the major transfusion 
transmitted infections such as HIV, Hepatitis C and Hepatitis B, other novel agents such 
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as prion proteins, which are responsible for prion disease or spongiform 
encephalopathy, have been recently recognized.23  
The risk of transfusion transmitted infection to the recipients is declining, both 
in developed and developing countries. This change is due to continuing improvements 
in donor selection and advanced testing for infectious agents.24 
Epidemiology of malaria 
 Malarial infection is a mosquito born protozoal infection of human host caused 
by a plasmodium parasite, commonly transmitted through the saliva of female 
Anopheles mosquitoes. 
Five species of plasmodium genus are (P. falciparum, P. vivax, P. ovale, P. 
malariae and P. Knowlesi.) identified with worldwide incidence of 300-500 million 
cases annually with 1.2 to 2.7 billion deaths from all clinical cases reported. 90% of the 
cases are reported from the sub Saharan African country. 
 According to the World Malaria Report 2011, Malaria is considered highest 
geographical distributution worldwide including 106 tropical and semitropical countries 
with 35 countries in central Africa having the highest burden of cases and deaths.25  
Estimated annual incidences of malaria vary worldwide. Estimates of The World 
Malaria Report, 2011, states that 216 million malaria cases in 2010, among this 
approximately 81%, or 174 million cases are from the African Region25, about 91% 
being due to P. falciparum.25 But the actual number of cases may be much more and 
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among  the estimated number of cases only 11% of confirmed cases were reported by 
national malaria control programmes.25 Hay et al have estimated 451 million (95% 
credible interval 349-552) clinical cases of P.falciparum malaria in 2007.26,27  
According to the estimates of The World Malaria Report, 2011, 81% were in the 
African Region followed by the South-East Asia 13% and Eastern Mediterranean 
Regions 5%.25  Hay et al reported that more than half of all estimated P. falciparum 
clinical cases occurred in Nigeria, the DRC, Myanmar (Burma) and India.26, 27 
13 
 
Figure : 1 
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Life cycle of malarial parasite 
Malarial parasite life cycle consists of two different life cycles in two different 
host, sexual cycle in mosquito and asexual cycle in humans, begins when the female 
anopheles mosquito inoculates saliva containing malarial sporozoites in to the blood 
stream during the blood meal. 
Asexual cycle 
Exoerythrocytic phase (hepatic phase) 
Sporozoites from the blood stream enter in to the liver parenchyma and develop 
in to hepatic schizonts. Each hepatic schizont ruptures and releases approximately 
10,000-30,000 merozoites in to the blood stream. Duration of hepatic phase for 
P.falciparum 5.5 days ,p.vivax 8 days,p.ovale 9 days,p.malariae 15 days . In p.vivax and 
ovale infection some parasites remain dormant in hepatic parenchyma and causes 
relapses this dormant form is known as hypnozoites. 
Erythrocytic phase 
  The merozoites from the blood stream invade the Red blood cells become 
trophozoites. After multiplication in the Red blood cells develop in to schizont stage 
around 48-72 hours. The schizont rupture and release merozoites, after multiplication of 
several erythrocytic cycles atleast 50 parasite/micro litre is required to produce clinical 
symptoms.  
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Sexual cycle 
Few infected erythrocytes produce gametocytes other than schizonts. These 
gametocytes (sexual form) enter the mosquito during the blood meal and produce oocyst 
after sexual reproduction in the mosquito. These oocysts rupture and release sporozoites, 
and migrate to the salivary gland of the mosquito.28 
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Figure : 2 
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In endemic areas asymptomatic P.vivax carrier-state is possible because of low-
parasitemic load and semi-immune status of the host. The asymptomatic individual can 
show recrudescence of infection in days or weeks or sometimes in months after initial 
infection.  P.vivax sporozoites in hepatocytes are known to remain dormant as 
hypnozoites, which can result in relapse after many months to years of asymptomatic 
carrier-state. 
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Malaria transmission 
Transmission of malaria parasites primarily occurs through the bite of the blood 
feeding female anopheles mosquito. Besides transmission by mosquitoes, direct 
inoculation is another well documented mode of acquiring malaria. Direct inoculation 
has resulted in malaria after accidental exposure in healthcare workers, among injecting 
drug users sharing used needles and in blood transfusion.29, 30 
Malaria transmission by transfusion is the most common form of direct 
inoculation.  
A review in 2005 found 22 published cases of occupational P. falciparum 
malaria following accidental blood exposure.31 All the cases were from non-endemic 
countries. Accidental exposure to infected blood may be challenging to diagnose in 
areas where infections are not endemic32 but with increasing travel to malaria endemic 
areas and the possibility of more patients being admitted and treated for malaria, this 
route may become more important in occupational health.31 
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Other modes of transmission 
1. Mother to the growing fetus (Congenital malaria): Transfer of parasitized red 
cells from infected mother to the child either transplacentally or during labor can 
lead to malaria in the newborn, which is known as congenital malaria.33 
2. Needle stick injury: Cases of malaria transmission through needle-stick injuries 
occur  accidentally among health care professionals and also due to needle 
sharing among drug addicts.34, 35 
3. Transfusion Transmitted Malaria: Malaria can be transmitted by transfusion of 
blood from infected donors and was first reported in 1911.36 One of the most 
common transfusion-transmitted infections to be prevented is transfusion 
malaria.34, 35 The risk of acquiring transfusion malaria is very low (1 case per 4 
million) in non endemic countries such as the United States, whereas in the 
endemic countries, it is much higher (>50 cases per million donor units). 35, 37 
  After subsequent malaria infection, the individual may remain infective for 
weeks to months, or even years, in case of P. malariae infection and proven carriers 
of P. malariae should never donate blood. The   transmission risk is elevated in 
transfusion of fresh, whole blood, particularly when the blood has been stored for less 
than 5 days and the risk is significantly lesser after 2 weeks.38 
   
20 
 
In case of transfusions of plasma, plasma components, or derivatives devoid of 
intact red cells the risk of transmission is extremely low.39 Most donors implicated in 
transfusion-transmitted malaria are predominantly semi-immune with very low parasite 
loads and the infectious dose is estimated to be 1 to 10 parasites in a unit of blood. 
Hence, it is difficult to identify malarial infection in donated blood specimens. 
Detection of such low parasitemia is difficult or impossible with the peripheral smear 
examination or even with more sensitive tests such as the antigen or polymerase chain 
reaction (PCR) assays in few occasions.6,40,41,42 
Although universal serological screening in non endemic regions is not cost-
effective, targeted screening of donors identified at risk by travel-based questioning can 
significantly reduce wastage.38 The development of automated protein microarray-based 
technology has the potential to further enhance antibody/antigen sensitivity.38 There are 
reports of successful use of Rapid Diagnostic Tests in screening donated blood.8 
In non-endemic countries, donor deferral in combination with screening for 
specific antimalarial immunoglobulin provides an effective means of minimizing the 
risk of malarial transmission. In addition, the administration of antimalarials to 
transfusion recipients may help to prevent transmission.6 In endemic regions due to high 
risk of transfusion malaria, it is also important to ensure that blood collected in highly 
endemic regions is not transfused to patients from areas of low endemicity.40 
Chemoprophylaxis was found to be particularly useful in endemic countries for 
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protecting young children with no or little malarial immunity from developing acute and 
potentially fatal post transfusion malaria42. 
Transfusion malaria manifests with a shorter incubation period of 2–4 days as 
the inoculum contains the erythrocytic forms of the parasite and pre-erthrocytic phase of 
the life cycle within the liver does not occur. Typical symptoms of fever, malaise, and 
headache occur and in case of P. falciparum infection, particularly in the non immune 
patients, the infection can progress rapidly into fatal illness. 
Diagnosis of transfusion malaria requires a keen sense of clinical suspicion and 
any recipient of blood transfusion developing such symptoms should be tested 
immediately for malaria. As the transfusion-acquired P. vivax malaria does not have the 
exo- erythrocytic phase, relapses do not occur.34, 35,37,43,44 
TTM in endemic countries  
Transfusion transmitted malaria is very difficult to differentiate from natural 
infection due to the endemicity of malaria .Many donors and patients in endemic areas are 
already infected or at high risk of malarial infection. Mohamed Siddig M. Ali et al in 
their study in Sudan found that the prevalence of post transfusion malaria in transfusion 
recipients was 3.5%, four days after transfusion.45 
All patients in the study (twelve) who received malaria positive blood screened 
by peripheral blood smear study became malaria positive. There were also two patients 
who did not receive malaria positive blood but still developed malarial parasitemia 4 
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days after transfusion. In malaria endemic countries post transfusion malaria cannot be 
equated to TTM because there are other sources of transmission. Naheed Ali et al in 
their study concluded TTM is a risk in malaria endemic country like Pakistan.46 
Anju Dubey et al in their study on seroprevalence of malaria in blood donors 
and multitransfused patients in northern India concluded that malaria antibody 
prevalence in blood donors was high and blood units donated by such donors have high 
risk potential and special processing may be undertaken to reduce the risk of TTM.47 
Okocha et al in their study on the prevalence of malaria parasitemia in blood 
donors in a Nigerian teaching hospital found that one in three blood transfusions carries 
the risk of transmitting malaria parasite to the recipient.48 
TTM in non-endemic countries 
Most of the data are of TTM from non-endemic countries for Malaria; this may be 
due to the ease of diagnosis in non-endemic countries compared to endemic countries 
where it cannot be proven whether malaria developed after post transfusion or from a 
reinfection or recrudescence. 
There were about 350 cases of TTM reported between 1911 and 1950.37  During the 
period of 1950 to 1972, 1756 cases had been reported in 49 countries. 
As transfusion of blood and its components increased, more cases of TTM were 
expected. On the other hand with an increased awareness of this problem, more 
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interventions have been introduced to reduce its occurrence including screening test and 
deferral of donors who have travelled to malaria endemic countries. 
In a study by SHOT, two confirmed cases of TTM have been reported from 1996 
till 2010 in UK49. In Japan, twenty two cases of TTM have been reported since 1945.50  
Three cases of TTM were reported in 2009 in US.51  Garraud et al in their study from 
1990-2006 in France found that there was one case of TTM reported for every three 
years.52 
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SEROPREVALENCE OF TRANSFUSION TRANSMITTED MALARIA 
Table : 1 
I. IN ENDEMIC COUNTRIES 
Author Country 
Malaria Study 
Group 
Malaria Antigen 
Prevalence 
Diop et al55 Senegal Blood donors 0.53% 
Saeed et al56 Saudi Arabia Blood donors 0.17% 
Lim CS et al57 Korea Blood donors 1.7% 
Choudhury N et al58 India Blood donors 0.35% 
Anju Dubey et al47 India Blood donors 0.09% 
Bahadur et al8 India Blood donors 0.03% 
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Table : 2 
II. IN NON-ENDEMIC COUNTRIES 
Author Country 
Malaria Study 
Group 
Malaria Antibody 
Prevalence 
Chiodini et al6 UK Blood Donors 0.45% 
Soler et al53 France Blood Donors 1.62% 
Seed et al54 Australia Malaria Exposed 
blood donors 
1.33% 
 
Saeed et al in their study at Saudi Arabia found the malaria prevalence rate 
among voluntary blood donors by antigen detection method by ELISA technique was 
0.17%. 56 
Diop et al in their study at Senegal found the malaria prevalence rate among 
blood donors by antigen detection method by ELISA technique was 0.53%.55 
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Table : 3 
Incubation period for TTM 
Falciparum Vivax Malaria Ovale 
7-13 days 8-12 days 24-28 days 12-14 days 
 
Parasite Viability in stored blood 
Plasmodium Parasites can survive in the refrigeration for up to 18 – 20 days at 
4degrees C. 6, 59 There were 7.1 fold reductions after 14 days but parasites remain 
detectable by microscopy for 28 days when the blood is stored at 4 degree C. Parasites 
did not show in vitro replication when cultured after 14 days storage. This shows that 
the viability of the parasite is reduced after prolonged refrigeration. 
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PREVENTION STRATEGY FOR TTM 
Screening test  
Direct and indirect methods are used as screening tests in the diagnosis of malaria Direct 
method is detection of antigen and indirect method is detection of antibody. 
Direct Method 
1) Peripheral smear 
2) QBC Quantitative Buffy coat method 
3) Immunochromatography / rapid test method 
Indirect Method 
1)  Enzyme-Linked Immunosorbent Assay 
2) Indirect Fluorescent Antibody Test 
3) Polymerase Chain Reaction 
Peripheral Smear 
 Two types of blood film preparation are used thick and thin. 
 Thick smear is for identification of parasite Thin smear   is for identification of 
species, 
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 For examination of thick film, 100 microscope fields should be looked at.60  
Microscopy has a limit of detection of 20 – 30 parasites per µl of blood and low 
parasiaemia can be missed by microscopists. 61, 62   Accurate determination of parasite 
density is done by thin film by counting the parasites against at least 100,000 red   blood 
cells.63  The stains that are used for peripheral smear are Giemsa and Leishman. 
Microscopy remains the gold standard for malaria diagnosis. 
Malaria Rapid Diagnostic Test 
Immunochromotographic or rapid diagnostic test is based on the capture of 
malarial antigens. Different formats are commercially available Dip Sticks, Cards, and 
Cassettes. The principle is same for all. Immunochromotographic procedures utilize 
monoclonal or polyclonal antibodies which are conjugated to either gold particles or 
liposome’s containing   selenium dye. It is used to capture malaria antigen. The migration 
of liquid across the nitro cellulose membrane allows capturing the malaria antigen to get 
bound to a second immobilized monoclonal antibody and produce the visible colored 
line.64 
There are two types of malarial antigens, histidine-rich protein -2 (HRP-2) and 
parasite lactate dehydrogenase pLDH. Plasmodia aldolase is another antigen introduced 
few years ago.65  It is found in all species of plasmodium.66 
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Histidine Rich protein-2 (HRP-2) 
HRP-2 is seen only in P.falciparum [hospital care for children] and kits with 
antibody against HRP-2 has got sensitivity of 85% and specificity of 100%.67 - 74 As HRP-
2 is present only in P.falciparum, antibody against HRP-2  cannot be used for the 
detection of other human malaria parasite such as P. vivax, P. ovale malaria.75 HRP-2 
persists in the blood stream after malarial episode so it cannot be used for anti-malarial 
therapy  monitoring.76 
Plasmodium Lactate Dehydrogenase (pLDH) 
The Plasmodium enzyme pLDH is produced by malaria parasite during the 
growth in Red Cells. All the four human malarial parasites produce a unique isomer of 
pLDH activity77 
Test for P.vivax is based on LDH and it has recently been developed and 
evaluated in the Republic of Korea78 in which P.vivax accounts for 99.9% of all malaria 
cases.79,80  The pLDH becomes negative soon after the parasite clearance. 
Sensitivity and Specificity of RDTs 
 RDTs have 88 – 100% sensitivity and 92-95% specificity for the detection of 
P.falciparum.81 The RDTs sensitivity decreases when the parasite density is less than 100 
parasites / µl.82 RDTs are not a replacement for microscopy but where microscopy is not 
possible RDTs should be introduced.83 
30 
 
RDTs have been used since early 1990s and they can perform with high 
accuracy.82 A new generation of 3 band RDTs use P.aldolase , pan malarial 
antigen(pLDH), in addition to HRP-2 to identify non-falciparum infections.84 This will  
distinguish P.falciparum from other species but it cannot differentiate between other non 
falciparum species. 
QBC Test principle 
The QBC analysis utilize the density gradient layering of stained blood cells with 
the expansion of micro hematocrit   buffycoat .The QBC technology is less dense, 
parasite infected cells concentrated within the separated red cells white cells layers of the 
spun QBC tube. QBC tube is internally coated with acrydine orange stain and anti-
coagulants .The main advantage of the acrydine orange dye is to visualize the malaria 
parasites. The centrifugally separated cell layers is achieved with plastic float ,inserted to 
the tube after filling the capillary or Venus blade and ceiling with the plastic closure the 
separated layers are clearly identifiable in the spun tube or dark and light red cells , 
granulocytes – lymphocytes – monocytes and platelets. Examining under the fluorescent 
microscope of the interface region of the right red cells and granulocytes permits the rapid 
and unambiguous detection of the stained malaria organ. 
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Figure : 3 
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Antigen detection by ELISA 
Enzyme linked immunoassays have been developed that are capable of detecting 
malaria antigens.86, 87, 88  The antigen which is being detected is HRP-2 same which is 
used for RDTs. In this technique, wells are coated with monoclonal antibodies against 
HRP-2 of P. falciparum.89 
Antigen ELISA has been recommended for evaluation in blood banks but 
surprisingly, there are not many published studies. A Recent study which was 
conducted among blood donors in Venezuela reported the sensitivity and specificity 
was very high 100% and 98% respectively.90 
Polymerase chain reaction  
The development of malaria nucleic acid amplification techniques has been 
based on the polymerase chain reaction method. PCR is a method which is used to 
amplify nucleic acid sequences of the malaria parasite which may be present in blood. 
Following PCR the amplification product can be detected using gel electrophoresis 
followed by ethidium bromide staining. Based on various modifications, different types 
of PCR methods available including multiplex PCR, nested PCR and real time PCR. 
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PCR is the most sensitive and specific method to detect malaria parasites.91 
Sensitive PCR techniques  have been developed that are capable of detecting parasites 
at a density of one per microlitre in contrast with 10-50 parasites per microlitre ,which 
is the threshold of an experienced microscopist.92  Such a highly sensitive and specific 
test would be ideal especially as low parasitemia is expected in donors but PCR requires 
advanced infrastructure is required for training personnel, quality control ,maintaining 
equipment and preventing contamination.84  Such a high cost will be unaffordable for 
many malaria endemic countries that are also developing countries. It is unlikely that 
PCR will be suitable for routine purposes in the near future93 although it may become 
more accessible in the longer term. 
Anti Malarial in blood bags 
The in vitro processing of donor blood with anti-malarial in blood bags to kill 
parasites before the blood is transfused has been suggested as an additional measure to 
prevent TTM. Two anti-malarial, quinine and sulfadoxinepyrimethamine (SP) have 
been used experimentally and found to effective against parasites in blood bags. 94, 95  In 
a study in Sudan, SP for example at a dose of 179.65 μg/L killed 99% of all parasites 
within 24 hours parasites. There are however concern that such an intervention can 
contaminate the blood bag and has the potential to increase the spread of resistance to 
the particular anti-malarial.96 In vitro processing of donor blood with anti-malarial has 
remained an experimental intervention and has not been used in blood for patients. 
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Medication to blood recipients 
Presumptive treatment of transfusion recipients in malaria endemic countries is 
recommended by the WHO97 and countries such as Kenya and Senegal have 
implemented this recommendation. There are only few data on the extent to which 
antimalarials are currently being used as presumptive treatment. In the past 
administration of antimalarials such as chloroquine to recipients of blood transfusion 
was in wide practice. Resistant to chloroquine has largely replaced more expensive 
artemisinin based therapy. This has increased 5-7 fold   the cost of treating all 
transfusion recipients with antimalarials making this practice unaffordable on a wide   
scale. 
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4.  MATERIALS AND METHODS 
A cross sectional study was conducted to study the prevalence of malaria among 
voluntary blood donors. Voluntary Blood Donors (VBD) was recruited from the blood 
bank of the department of Transfusion medicine and Immunohematology of the Tamil 
Nadu Dr.M.G.R.Medical University, Chennai, Tamil Nadu.  All the study participants 
were selected by the following selection criteria.   
INCLUSION CRITERIA:  
      Voluntary Blood Donors as per the eligibility criteria given in the Technical 
Manual  of the Directorate General of Health Services. 
EXCLUSION CRITERIA:  
       Voluntary blood donors - not willing to participate in the study. 
ESTIMATED SAMPLE SIZE  
  Sample Size was calculated by 
     N=   Z2  P (1-P) / d2          
Where N = Sample Size 
                   Z = Z statistic for a level of confidence. 
                   P = expected prevalence or proportion  
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                   d = Precision 
         Z statistic (z): CI-95%, Z value is 1.96 
 
   N = (1.96)2 x 0.1 (1-0.1) / (0.05)2 = 144  
               10% prevalence the sample size is 144,  
                The sample size is around- 150  
Laboratory Methods 
2ml of EDTA blood sample was collected from the donor and used for screening 
malaria parasite by 
1. Peripheral blood smear 
2. Quantitative Buffy Coat method. 
3. Rapid Card Test 
Data Collection Method 
After obtaining the informed consent from the donor, a semi-structured 
questionnaire (standard Voluntary donor form) was used to obtain information on 
demographic details and other risk factors such as previous history of malaria, treatment 
taken for malaria etc.  
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Peripheral Smear Method 
Microscopic examination of the blood films is known as the current universal 
“gold standard”. 
Method for the diagnosis of the malaria 
Preparation of thick film 
A small drop of blood taken from the EDTA blood sample placed over the clean 
glass slide and thick blood film made with the help of another glass slide spreading it out 
about 1cm2 
Surface area. The exact thickness of the blood film can be accessed by placing a 
piece of newspaper over the prepared blood film and the print should be visible. Allowed 
the film to dry at 370 C for 30 minutes or 50 to 600 C. for seven minutes. 
Commercially available Leishman’s stain was used to stain the  thick film of peripheral 
smear. 
1) After deheamoglobinised with distilled water the  thick film is stained with 
Leishman stain 
2) The film is kept in the rack for 30 sec to 1 Min to get fixed 
3) Then buffered distilled water is added twice the amount at a pH of 7.2 
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4) Allowed the stain for ten minutes undisturbed 
5) Washed the stain with Tap water. 
Thin Blood Film 
If the parasites are seen in the thick film, the thin film should be examined to 
determine the species. The thin film morphological identification of the parasite to species 
level in thin film is easier and has greater specificity when compared to thick film. This 
method is made as a choice for routine screening in which parasitemia is very low. 
Examination of thin blood film 
Parasitemia is estimated by finding the number of parasitized RBC in 10,000 
RBC. The number  of  parasitized  cells is expressed as percentage. Roughly the number 
of parasites present in one micro liter is calculated by assuming that one micro liter of 
blood contains 5 x 106 RBC;  1 percent of parasitemia contains 1 percent per 100 RBC. 
The stained film is examined under oil immersion microscope. 
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Figure : 4 
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Quantitative Buffy Coat Method 
Quantitative Buffy coat method was done with acridine orange dye which stains 
nucleus and cytoplasm by binding with DNA and RNA. The presence of parasite and its 
morphology examined under fluorescent microscopy after excited at 480 nm, the 
nucleus show yellowish green and the cytoplasm show bright red fluorescence. The 
general morphology and outline structure of the parasite are   well preserved like 
specimens stained by the giemsa stain.Red blood cells will not emit fluorescence colour 
due to absence of staining by acridine orange dye. 
 The quantitative Buffy coat  capillary tubes are available with 75mm and 
1.677mm in length and diameter respectively coated with anticoagulants EDTA and 
heparin at the top of the tube     and(fill end)and acridine orange dye with potassium 
oxalate at the opposite end . 
  The QBC tube filled with approximately 55-65 microlitres to dissolve residues 
in the sample QBC tubes are rotated for 10 seconds. 
 The plastic float with a specific gravity of 1.055 which is midway between 
plasma and RBC and 20mm in size is used to create 40micron space between the 
interior and exterior of the inserted plastic float to achieve expansion of cell layers 
which is centrifugally separated. 
After centrifuge at 12,000g for 5 minutes the tubes are examined under oil 
immersion   by focusing under the Buffy coat, the area around the plastic float. 
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The presence of malarial parasite DNA and RNA is identified by the green and 
orange fluorescence emitted respectively. 
Every tube was examined until the presence of parasite or for maximum five 
minutes 
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Figure : 5 
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Figure : 6 
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Rapid Card Test 
The immunochromatographic rapid kid components are used after checking the 
colour of reagents which is blue in colour normally if it is pink or colourless should be 
discarded. 
  The test kid ready to use after bringing it to the room temperature port A in the 
test kid filled with 5 microlitre of anticoagulated blood by micropipette and allowing it 
mix evenly in port B two drops of buffer solution delivered vertically with the help of 
plstic dropper.   
  The results are interpreted after 20 minutes. Two pink-purple bands in the Pf and 
Pan Region in the test window T along with control band indicate positive for 
plasmodium falcipaeum or mixed infection. Only one pink-purple band in control 
indicate negative result and one pink-purple band in Pan Region at test window T along 
with control indicate positive for other species  
  The following results indicate invalid test. 
1. Absence of bands in all regions  
2. Presence of bands only in test region without control band. 
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Figure : 7 
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Informed Consent Form  
 Study objective was explained to the participants and then informed written 
consent was obtained in vernacular language as per the format enclosed. 
Ethical Issues 
 In this study, human beings were used for the study and also invasive procedures 
were involved. Hence, human ethical clearance was obtained from the IRB of The 
Tamil Nadu Dr.M.G.R.Medical University. (Copy Enclosed). 
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5. RESULT 
A total of 250 blood donors were enrolled for this study. Of which 30 % of the 
donors + were in the age group of less than 22years followed by 26% who were in the age 
group of  26-33years.  In our study malarial parasite positive donor was in the age group 
of less than 22 years. 
Table :    3 
Age Distribution of Voluntary Blood Donors 
 
Age in years No.of Donors Percentage 
<22 76 30.4% 
22-26 52 20.8% 
26-33 65 26% 
>33 57 22.8% 
Total 250 100% 
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Figure : 8 
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Table : 5 
 
Distribution of Age among gender 
Sex Mean age 
in yrs 
Median 
(yrs) 
Range(yrs) Min (yrs) Max (yrs) 
Male 28.49 27.00 35 18 53 
Female 20.29 20.00 8 18 26 
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MICROSCOPY FOR MALRIAL PARASITE SCREENING 
Malarial parasite was observed under microscope by using thick and thin film. P.vivax 
gametocyte stage was observed under the microscope 
Figure : 14 
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Quantitative Buffy Coat Method 
By this method  also the same type of parasite was observed as showed in the picture 
below. 
Figure : 15 
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Figure : 16 
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Figure : 17 
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RAPID CARD TEST 
This test is a non-species specific test. According to the manufacture instruction, 
HRP band is to detect P.Falciparum and other band is for other type of plasmodium 
species. In the positive card test, Positve band was observed only in non-species 
specific  band.Hence we concluded that it could be other than P.falciparum 
Figure : 18 
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In our study among the 250 donors, one donor was found to be positive for malaria.  
The below table shows the malaria positivity with the previous history of malarial 
infection (four months back). This shows that there was a statistically significant 
association by fisher’s exact test (p-value-0.004) 
Table : 9 
Correlation between Donor with Previous History of Malaria and Serological 
Positivity 
Past history of malaria Malaria  Seropositivity Chi-
Square 
p- Value 
(FISHER’S 
Exact Test)
Present 
 
Absent Total Positive Negative Total
1 249 250 1 249 250 0.000 0.004 
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Table : 10 
 
Correlation between Anti Malarial treatment and positivity for Malaria among 
VBD 
Previous history of 
treatment  for malaria 
Positive Malaria 
Total 
Chi-
Square 
p- 
Value 
Present Absent Total Positive Negative 
1 249 250 1 249 250 0.000 0.004 
 
In the present study, one donor who had taken antimalarial drugs four months 
prior to the donation was found to be positive for malaria. Here also we found the 
significant association and the p value was 0.004. 
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SENSITIVITY AND SPECIFICITY OF QBC AND RDT WITH RESPECT TO 
GOLD STANDARD MICROSCOPY 
             Among the various tests for detection of malarial parasites, Microscopy has 
been considered as the Gold Standard method. In our study, QBC and RDT were 
compared with the gold standard microscopy. 
Table: 11 
Comparison of diagnostic test with Gold standard 
QBC 
MICROSCOPY 
TOTAL 
POSITIVE NEGATIVE 
POSITIVE 1 0 1 
NEGATIVE 0 249 249 
TOTAL 1 249 250 
 
SENSITIVITY   
         a 
                        =     -------  x 100  
                                a+c       
 
 
                                  1 
                        =     -------  x 100 = 100% 
                                  1       
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SPECIFICITY  
         d 
                        =     -------  x 100  
                                 b+d       
                                249 
                        =     -------  x 100 = 100% 
                                249       
POSITIVE PREDICTIVE VALUE 
                                 a 
                        =     -------  x 100  
                                a+b       
                         
 
         1 
                        =     -------  x 100 = 100% 
                                 1       
NEGATIVE PREDICTIVE VALUE 
                                 d 
                        =     -------  x 100  
                                c+d       
 
 
                                249 
                        =     -------  x 100 = 100% 
                                249       
 
Since we found only one positive among the entire test the Sensitivity and 
Specificity of the QBC were 100% with respect to the gold standard test microscopy. 
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Table : 12 
Sensitivity and specificity of rapid diagnostic test with respect to microscopy 
 
SENSITIVITY   
         a 
                        =     -------  x 100  
                                a+c       
 
 
                                  1 
                        =     -------  x 100 = 100% 
                                  1       
 
SPECIFICITY  
 
         d 
                        =     -------  x 100  
                                 b+d       
 
 
                                249 
                        =     -------  x 100 = 100% 
                                249       
 
 
RDT 
MICROSCOPY TOTAL 
POSITIVE NEGATIVE 
POSITIVE 1 0 1 
NEGATIVE 0 249 249 
TOTAL 1 249 250 
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POSITIVE PREDICTIVE VALUE 
                                 a 
                        =     -------  x 100  
                                a+b       
 
                           
         1 
                        =     -------  x 100 = 100% 
                                 1       
 
NEGATIVE PREDICTIVE VALUE 
 
 
                                 d 
                        =     -------  x 100  
                                c+d       
 
 
                                249 
                        =     -------  x 100 = 100% 
                                249       
 
The Sensitivity and Specificity of the Rapid Diagnostic Test were 100% with 
respect to the Microscopy method. In the present study, sensitivity and specificity of 
QBC and RDT were 100% with respect to the gold standard microscopy. 
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6. DISCUSSION 
The present study screened 250 voluntary blood donors to know the 
prevalence of malaria and to compare the sensitivity of three different techniques 
(Microscopy, QBC, and RDT) for malarial screening. Voluntary blood donors with 
asymptomatic infection of malarial parasite contribute to the risk of Transfusion 
Transmitted Malaria. 
 In our blood bank, we strictly follow 100% voluntary blood donation. All the 
donors included in the study were   voluntary blood donors. Hence the prevalence of 
TTI infection was very low in this study. 
In our study out of 250 donors one was found to be positive for HBsAg and an 
another donor was found to be positive for malaria. 
Gupta et al reported increased seropositivity of HIV, Anti HCV and HBsAg in 
replacement donors when compared to voluntary donors.16 
Ekadashi et al from New Delhi, reported that Syphilis and HIV seropositivity 
were more among replacement donors when compared to voluntary donors.98 
In the present study, the most common age group of voluntary blood donors 
were less than 22 years (30.4%) with overall sex distribution of 94% males and 6%  
females. 
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In the present study, among the 250 voluntary blood donors, one donor was 
positive for malaria by Microscopy, QBC and Antigen Detection Rapid Diagnostic 
Test. The prevalence rate of malaria in our donor study population was 0.4%. 
Similar to our study, Bahadur et al in their study found malaria antigen 
prevalence rate of 0.03% among blood donors by immunochromatographic method. 
In their study, out of 11,736 units screened, three units were found positive for 
malarial antigen.  
Among these three positive samples, 2 were positive for P.vivax and 1 was 
found to be positive for P.falciparum.  These three cases were also found to be 
positive by microscopy.  
Hence, they concluded that the use of rapid detection devices along with 
peripheral smear study of positive donor is a reliable method to prevent transfusion 
transmitted malaria in India.8  
In concordance with our study, Choudry N et al. in their study conducted in 
northern India found the prevalence rate among voluntary blood donors to be 0.35% 
by antigen detection method. 58 
Lim CS et al in their study conducted in Korea among blood donors found the 
malarial antigen prevalence rate to be 1.7% by PCR method. In comparison to our 
study, the high antigen prevalence rate in their study   was due to highly sensitive 
detection   method.57  
68 
 
Saeed et al in their study conducted in Saudi Arabia   found the prevalence 
rate among voluntary blood donors to be 0.17% by antigen detection ELISA method. 
This is similar to our study.56 
Similar to our study, Diop et al in their study conducted in Senegal found that 
the prevalence rate among blood donors to be 0.53% by antigen detection ELISA 
method.55 
Anju Dubey et al   in their study in northern India reported that none of their 
donors were found positive by either Microscopy or antigen detection RDT. 
However, one of the donors who were deferred with history of malaria was found 
positive by antigen detection RDT and negative by microscopy, which accounts for 
0.09% prevalence rate by antigen detection RDT among blood donors.  
Therefore, they concluded that blood donor screening by Microscopy may not 
be an acceptable method, as more sensitive malaria screening methods like RDT, 
malaria antigen testing by ELISA are available.47 This is similar to our study with 
respect to the past history of malaria and positive antigen detection RDT. However, in 
our study microscopy also found to be positive. 
In the present study, sensitivity and specificity of QBC and RDT were 100% 
with respect to the gold standard microscopy. 
          SC Parija et al in their study compared microscopy (gold standard), QBC and 
antigen detection test and reported the sensitivity and specificity of QBC were 78.94% 
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and 98% respectively while sensitivity and specificity of RDT were 75% and 100% 
respectively.99 
          Mishra et al in their study reported the sensitivity and specificity of RDT for 
detection of P.vivax was 100% and the sensitivity and specificity of RDT for detection 
of P.falciparum was 96% and 100% respectively when compared with microscopy as 
gold standard.100 
In 2008, Bharti et al  in their study at New Delhi evaluated the usefulness of 
new rapid diagnostic test (HRP2/ pLDH Malaria card test) for malaria diagnosis in 
the forested belt of central India. Their analysis revealed that in comparison to 
microscopy RDT was 93%sensitive, 85% specific with a positive predictive value of 
79% and a Negative predictive value of 95%.101 
          
 
 
 
 
 
 
70 
 
Table : 13 
 
The advantage and disadvantage of Microscopy are given below: 
S.No Advantage Disadvantage 
1 Gold Standard It requires well  trained 
microscopists 
2 Inexpensive ,   when compared to other 
methods 
Less sensitive  
3 No need for any special instrumentation. Time consuming 
4 No storage or refrigeration required 60 – 120 mins 
5 Non-Biodegradable substance are not used It is Subjective 
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Table : 14 
 
The advantage and disadvantage of QBC are given below: 
S.No Advantage Disadvantage 
1 Shorter duration (5 – 30 minutes)  It is expensive 
2 High Sensitivity Needed a special 
instrumentation 
3 Highly reliable and user friendly Needed a well trained and 
experience Microscopists 
4 Different stages of parasite concentrated in a 
narrow zone can be viewed easily 
Artifacts 
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Table : 15 
 
The advantage and disadvantage of RDT are given below: 
S.No Advantage Disadvantage 
1 Easy to use with 
minimal training 
required 
It is costlier than Microscopy method 
2 Plasmodium species 
can be detected 
Exposure to extreme temperature can result in poor 
performance of RDTs 
3 The test can be 
performed without 
Laboratories 
HRP2 alone kits detect only plasmodium falciparum 
4 Time duration is less 
than 5 – 20 mins. 
Intensity of the test band varies with amount of 
antigen present at low parasite densities. This leads 
to reader variation in test results 
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7. SUMMARY 
 This cross sectional study was conducted on 250 voluntary blood donor blood 
samples in Chennai, to find out the prevalence of malaria and to compare the 
sensitivity of three screening tests viz., Microscopy, QBC and RDT.  
• The prevalence of malaria among the voluntary blood donors was 0.4%. 
• Among 250 donors, one of the donor blood samples was found to be positive 
by Microscopy, QBC and RDT. The species identified was P.vivax. 
• Malaria positive donor was observed in the age group of 22 years. 
• The positive case was detected in the male gender. 
• The infected donor was B blood group with Rh positive 
• The sensitivity and specificity of QBC and RDT were 100% with respect to 
the gold standard microscopy. 
• The positive asymptomatic donor had past history of malaria, for which he 
was treated with antimalarial drugs   four   months prior to blood donation. 
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8. CONCLUSION 
In our study, among 250 voluntary blood donors in a malarial endemic area 
one sample was found positive by microscopy, Quantitative Buffy Coat Method and 
Rapid Diagnostic Test. 
           Since intermittent asymptomatic period, recrudescence and relapse are known 
with P.vivax infection in an endemic area, especially in semi-immune individuals, it 
is imperative to screen all donors by less-laborious, less time-consuming and more 
sensitive methods, irrespective of a strict donor questionnaire.   
RDT in our study was found equally sensitive to QBC and microscopy. QBC 
is more sensitive; however it needs specialized instruments, higher technical expertise 
and is costlier compared to RDT.  
Hence, to prevent transfusion transmitted malaria in endemic areas like India 
screening of malaria by RDT may be included along with microscopy. However, a 
study on large number of voluntary blood donors is necessary to arrive at a definitive 
conclusion. 
   
75 
 
Even technically superior PCR method can miss very low parasitemic load 
causing transfusion transmitted malaria, strict donor deferral criteria and antibody 
screening may be considered similar to non-endemic areas.  
But, this would definitely lead to shortage of donor pool and more wastage of 
collected units. If necessary, antibody screening positive units can be subjected to 
pathogen inactivation or alternatively post-transfusion chemoprophylaxis may be 
tried.  
i 
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